FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome

Human Molecular Genetics

Volumn 12, Issue 10, 2003, Pages 1179-1185

  Kriederman, Benjamin M ^a   Myloyde, Teressa L ^a   Witte, Marlys H ^a   Dagenais, Susan L ^b   Witte, Charles L ^a   Rennels, Margaret ^a   Bernas, Michael J ^a   Lynch, Michelle T ^a   Erickson, Robert P ^a   Caulder, Mark S ^b   Miura, Naoyuki ^c   Jackson, David ^d   Brooks, Brian P ^e   Glover, Thomas W ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR MALFORMATION; CLINICAL FEATURE; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DISEASE ASSOCIATION; EYELID DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE DISRUPTION; GENE TARGETING; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE WALL; LEG SWELLING; LIVER; LYMPH FLOW; LYMPH NODE HYPERPLASIA; LYMPHATIC SYSTEM; LYMPHEDEMA; LYMPHEDEMA DISTICHIASIS SYNDROME; MALE; MESENCHYME; MESENTERY LYMPH NODE; MOLECULAR MECHANICS; MOUSE; MOUSE MUTANT; MUSCLE MALFORMATION; NONHUMAN; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; EYELASHES; FORKHEAD TRANSCRIPTION FACTORS; GENES, DOMINANT; HETEROZYGOTE; HUMANS; LYMPHATIC ABNORMALITIES; LYMPHEDEMA; MICE; TRANSCRIPTION FACTORS;

ANIMALIA; MEIBOMIA;

EID: 12444342654     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg123     Document Type: Article

References (31)

1. Falls, H.F. and Kertesz, E.D. (1964) A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans. Am. Ophthal. Soc., 62, 248-275.
2. Erickson, R.P., Dagenais, S.L., Caulder, M.S., Downs, C., Jones, M.C., Kerstjens-Frederikse, W.S., Lidral, A., McDonald, M., Nelson, C., Witte, M. et al. (2001) Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J. Med. Genet., 38, 761-766.
3. Kinmonth, J.B. (1972) The Lymphatics: Diseases, Lymphography and Surgery. Edward Arnold, London.
4. Dale, R.F. (1987) Primary lymphoedema when found with distichiasis is of the type defined as bilateral hyperplasia by lymphography. J. Med. Genet., 24, 170-171.
5. Fang, J.M., Dagenais, S.L., Erickson, R.P., Arlt, M.F., Glynn, M.W., Gorski, J.L., Seaver, L.H. and Glover, T.W. (2000) Mutations in FOXC2 (MFH-I), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet., 67, 1382-1387.
6. Finegold, D.N., Kimak, M.A., Lawrence, E.C., Levinson, K.L., Cherniske, E.M., Pober, B.R., Dunlap, J.W., and Ferrell, R.E. (2001) Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet., 10, 1185-1189.
7. Bell, R., Brice, G., Child, A.H., Murday, V.A., Mansour, S., Sandy, C.J., Collin, J.R.O., Brady, A.F., Callen, D.F., Burnand, K. et al. (2001) Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum. Genet., 108, 546-551.
8. Brice, G., Mansour, S., Bell, R., Collin, J.R., Child, A.H., Brady, A.F., Sarfarazi, M., Burnand, K.G., Jeffery, S., Mortimer, P. et al. (2002) Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet., 39, 478-483.
9. Traboulsi, E.I., Al-Khayer, K., Matsumoto, M., Kimak, M.A., Crowe, S., Wilson, S.E., Finegold, D.N., Ferrell, R.E. and Meisler, D.M. (2002) Lymphedema-distichiasis syndrome and FOXC2 gene mutation. Am. J. Ophthal., 134, 592-596.
10. Iida, K., Koseki, H., Kakinuma, H., Kato, N., Mizutani-Koseki, Y., Ohucki, H., Yoshioka, H., Noji, S., Kawamura, K., Kataoka, Y. et al. (1997) Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development, 124, 4627-4638.
11. Winnier, G.E., Hargett, L. and Hogan, B.L. (1997) The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev., 11, 926-940.
12. Winnier, G.E., Kume, T., Deng, K., Rogers, R., Bundy, J., Raines, C., Walter, M.A., Hogan, B.L.M. and Conway, S.J. (1999) Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev. Biol., 213, 418-431.
13. Smith, R.S., Zabaleta, A., Kume, T., Savinova, O.V., Kidson, S.H., Martin, J.E., Nishimura, D.Y., Alward, W.L.M., Hogan, B.L.M. and John, S.W.M. (2000) Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet., 9, 1021-1032.
14. Witte, M.H., Bernas, M.J., Martin, C.P. and Witte, C.L. (2001) Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Tech., 55, 122-145.
15. Wigle, J.T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M.D., Jackson, D.G. and Oliver, G. (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J., 21, 1505-1513.
16. Jussila, L. and Alitalo, K. (2002) Vascular growth factors and lymphangiogenesis. Physiol. Rev., 82, 673-700.
17. Wigle, J.T. and Oliver, G. (1999) Prox-1 function is required for the development of the murine lymphatic system. Cell, 98, 769-778.
18. Kaipainen, A., Korhonen, J., Mustonen, T., Van Hinsbergh, V.W.M., Fang, G., Dumont, D., Breitman, M. and Alitalo, K. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl Acad. Sci. USA, 92, 3566-3570.
19. Dumont, D., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M. and Alitalo, K. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science, 282, 946-949.
20. Karkkainen, M.J., Saaristo, A., Jussila, L., Karila, K.A., Lawrence, E.C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M.I. et al. (2001) A model for gene therapy of human hereditary lymphedema. Proc. Natl Acad. Sci. USA, 98, 12677-12682.
21. Irrthum, A., Karkkainen, M.J., Devriendt, K., Alitalo, K. and Vikkula, M. (2000) Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet., 67, 295-301.
22. Karkkainen, M.J., Ferrell, R.E., Lawrence, E.C., Kimak, M.A., Levinson, K.L., McTigue, M.A., Alitalo, K. and Finegold, D.N. (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet., 25, 153-159.
23. Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M.H., Jackson, D. et al. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell, 3, 411-423.
24. Petrova, T.V., Makinen, T., Makela, T.P., Saarela, J., Virtanen, I., Ferrell, R.E., Finegold, D.N., Ketjaschki, D., Yla-Herttuala, S. and Alitalo, K. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J., 21, 4593-4599.
25. Ayadi, A., Zheng, H., Sobieszczuk, P., Buchwalter, G., Moerman, P., Alitalo, K. and Wasylyk, B. (2001) Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J., 20, 5139-5152.
26. Yuan, L., Moyon, D., Pardanaud, L., Breant, C., Karkkainen, M.J., Alitalo, K. and Eichmann, A. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development, 129, 4797-4806.
27. Carlsson, P. and Mahlapuu, M. (2002) Forkhead transcription factors: key players in development and metabolism. Dev. Biol., 250, 1-23.
28. Kume, T., Deng, K. and Hogan, B.L.M. (2000) Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development, 127, 1387-1395.
29. Gronning, L.M., Cederberg, A., Miura, N., Enerbäck, S. and Taskén, K. (2002) Insulin and TNFa induce expression of the forkhead transcription factor gene Foxc2 in 3T3-L1 adipocytes via PI3K and ERK 1/2-dependent pathways. Mol. Endocrinol., 16, 873-883.
30. Cederberg, A., Gronning, L.M., Ahrén, B., Taskén, K., Carlsson, P. and Enerbäck, S. (2001) FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell, 106, 563-573.
31. Banerji, S., Ni, J., Wang, S., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol., 144, 789-801.